Wang Yuedan, a professor at Peking University Health Science Center's immunology school, said rising public concern about vaccine quality prompted the regulator to release more information on substandard products.

北京大学医学部免疫学系教授王月丹称，公众对疫苗质量的担忧日益加剧，促使监管机构公布了更多关于不合标准产品的信息。

"The latest disclosure of market denial is not directly linked to stricter vaccine management. It's more of an answer to public demand for more information on the production and supervision of rabies vaccines," he said.

他表示：“最新披露的市场准入情况，与更严格的疫苗管理并无直接关系。这更多地是为了回应公众对狂犬病疫苗生产和监督的更多信息的需求。”

Zeng Guang, an epidemiologist at China's Center for Disease Control and Prevention, said it's crucial to promote dialogue between the drug regulator, vaccine manufacturers and the public.

中国疾病预防控制中心流行病学专家曾光称，促进药品监管机构、疫苗制造商和公众之间的对话至关重要。

"Manufacturers should be notified of their products' problems to improve production," he said. "And the public is also entitled to be aware of quality issues."

他表示：“制造商应该被告知他们的产品存在的问题以改善生产。公众也有权意识到质量问题。”

【吉林两家企业10万瓶狂犬疫苗被拒绝签发】相关文章：

★ 养蜂专家被10万只蜜蜂附体毫发无伤

★ 最潮的衬衣穿着方法

★ 40岁年龄差，国王“迷弟”如何日常粉“爱豆”达•芬奇

★ 特朗普女儿伊万卡想打女权牌，结果玩脱了反被狂骂

★ 美发布“僵尸预警指南” 指导民众避难

★ 今天会是美好的一天

★ 2018年中国票房突破600亿！“好成绩”背后也有忧

★ 《小猪佩奇》性别歧视？伦敦消防局批其用词不当

★ 幼儿园的小女孩都开始化妆了？韩国美妆低龄化惹争议

★ Hello Kitty将被拍成好莱坞电影 动画版还是真人版待定